SELLAS Life Sciences Group, Inc.
SLS· Nasdaq
SELLAS Life Sciences Group, Inc.
- Last sale
- Oct 1, 2026 · -7.81%
- Market cap
- $2.29B
- 201.95M shares
- Filings
- 1,006
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $1,000,000 | reported | |
| FY 2021 | 2021-12-31 | $7,600,000 | reported | |
| FY 2020 | 2020-12-31 | $1,900,000 | reported | |
| FY 2019 | 2019-12-31 | $0 | reported | |
| FY 2014 | 2014-12-31 | $9,319,000 | reported | |
| FY 2013 | 2013-12-31 | $2,487,000 | reported | |
| FY 2012 | 2012-12-31 | $0 | reported |
SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR
